latest news releases from the newsroom
Pro Motors Group, Corp.
Pro Motors Group Corp.'s Ford Fusion Exceeds 65 Miles Per Gallon
LOS ANGELES, June 26, 2008 (PRIME NEWSWIRE) -- Pro Motors Group Corp. (Pink Sheets:PMGU), www.ProMotorsGroupCorp.com, announced today the results of several performance-based tests conducted after its successful installation of a Hydrogen Assist Fuel Cell in a 2006 standard Ford Fusion. Prior to the installation of the Hydrogen Assist Fuel Cell, the Ford Fusion received 25-28 miles per gallon (mpg), highway. Following the installation, the same Ford Fusion averaged 65-67 mpg, highway; nearly a 150% increase.
Lantis Laser's Dental Diagnostic Imaging System Can Address ADA's Recommendations for Placement of Sealants
DENVILLE, N.J., June 26, 2008 (PRIME NEWSWIRE) -- Lantis Laser Inc. (Pink Sheets:LLSR) (http://www.lantislaser.com), wishes to draw attention to new, recently introduced, clinical recommendations from the American Dental Association Council on Scientific Affairs to assist clinicians in their decision-making process, for the use of composite plastic sealants over very early decay on the occlusal biting surface of teeth in children, adolescents and young adults to stop the disease from progressing.
Integra LifeSciences Holdings Corp.
Integra LifeSciences Announces the Launch of the Tibiaxys Plating System
PLAINSBORO, N.J., June 26, 2008 (PRIME NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today the introduction of the Tibiaxys(TM) Plating System. The Tibiaxys(TM) Plating System has received clearance from the United States Food and Drug Administration (FDA), and a CE Mark Certification in the European Union, The Tibiaxys(TM) Plating System was designed with the help of Professor Beat Hintermann, MD, Kantonsspital, Liestal, Switzerland.
DelSite Announces Development of Unique Synthetic Typhoid Vi Polysaccharide Vaccine Candidate
IRVING, Texas, June 26, 2008 (PRIME NEWSWIRE) -- DelSite Biotechnologies, Inc., a wholly-owned subsidiary of Carrington Laboratories, Inc. (OTCBB:CARN), today announced that it has developed a proprietary synthetic typhoid fever vaccine candidate based on a novel plant polysaccharide (high-molecular-weight polygalacturonic acid, HPGA) that holds the potential to greatly enhance production and use of typhoid fever vaccine worldwide.
Vostok Nafta Investment Ltd
Vostok Nafta: KINNEVIK AND VOSTOK NAFTA EXTEND THE OFFER FOR KONTAKT EAST
The acceptance period is extended to allow for the shareholders who have not
yet accepted the Offer to tender their shares
Stockholm, 26 June 2008 — On 26 May 2008, Investment AB Kinnevik (publ)
(“Kinnevik”) and Vostok Nafta Investment Ltd. (“Vostok Nafta”) (jointly, the
“Bidders”), through their jointly owned Swedish company Vosvik AB, registration
number 556757-1095 (“Vosvik”), announced an offer for all the shares in Kontakt
East Holding AB (publ) (“Kontakt East”) at a price of SEK 35 in c